About Truveris
Truveris is a company based in New York (United States) founded in 2009. Truveris has raised $68.7 million across 7 funding rounds from investors including New Leaf Venture Partners, Canaan and McKesson Ventures. The company has 156 employees as of December 31, 2022. Truveris offers products and services including Truveris Marketplace and truGuard. Truveris operates in a competitive market with competitors including Express Scripts, Prescryptive Health, MedImpact Healthcare Systems, Waltz Health and RxBenefits, among others.
- Headquarter New York, United States
- Employees 156 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Truveris Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$68.7 M (USD)
in 7 rounds
-
Latest Funding Round
$15 M (USD), Series E
May 14, 2024
-
Investors
New Leaf Venture Partners
& 5 more
-
Employee Count
156
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Truveris
Truveris offers a comprehensive portfolio of products and services, including Truveris Marketplace and truGuard.
Platform for accessing and selecting pharmacy benefit plans affordably.
Tool to monitor and manage pharmacy plan contracts effectively.
People of Truveris
Unlock access to complete
Unlock access to complete
Funding Insights of Truveris
Truveris has successfully raised a total of $68.7M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $15 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Truveris
Truveris has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include New Leaf Venture Partners, Canaan and McKesson Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life sciences are managed.
|
Locked | Locked | Locked | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
Investments are directed by McKesson Ventures toward early-stage healthcare startups.
|
Locked | Locked | Locked |
Investor details for Truveris
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Truveris
Investment portfolio details for Truveris
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Truveris
Detailed financials for Truveris
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Truveris Comparisons
Peer comparison for Truveris
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Truveris
Truveris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Express Scripts, Prescryptive Health, MedImpact Healthcare Systems, Waltz Health and RxBenefits, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacy benefit management services are delivered through SaaS platforms.
|
|
| Locked | Locked | Locked |
A platform for pharmacy benefit management solutions is provided.
|
|
| Locked | Locked | Locked |
Pharmacy benefit management solution for payers, providers and employers
|
|
| Locked | Locked | Locked |
Prescription costs are managed via AI for payers and consumers.
|
|
| Locked | Locked | Locked |
Services and consultancy for pharmacy benefit management are provided.
|
Detailed competitors of Truveris
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Truveris
Complete news archive for Truveris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Truveris
Truveris was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Truveris is headquartered in New York, United States. It is registered at New York, New York, United States.
Garrett W. Fienberg is the current CEO of Truveris.
Truveris is a funded company, having raised a total of $68.7M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Truveris is 156.
HealthTech Analytics and Validation platform. A health information technology company delivering pharmacy data validation, analytics, and pricing solutions through a SaaS platform. Truveris products include TruGuard (claim validation), TruBid (online auction and RFP tool), and TruReport (prescription claim analytics). They also have a product called rxDash RxDash which is a pharmacy plan modeling, pricing, and reporting solution that helps to give everyone on the pharmaceutical continuum to see the impacts of pricing changes quickly and transparently. Truveris is backed by New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures, and First Round Capital.
Truveris's top competitors include Express Scripts, MedImpact Healthcare Systems and Waltz Health.
Truveris offers Truveris Marketplace and truGuard.
Truveris has 6 investors. Key investors include New Leaf Venture Partners, Canaan, McKesson Ventures, Tribeca Venture Partners, and NAV.VC.